Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeMY
Item Type Journal Article
Title Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies
Creator Lamy et al.
Author Pierre-Jean Lamy
Author Florence Castan
Author Nicolas Lozano
Author Cécile Montélion
Author Patricia Audran
Author Frédéric Bibeau
Author Sylvie Roques
Author Frédéric Montels
Author Anne-Claire Laberenne
Abstract The detection of the BRAF V600E mutation in melanoma samples is used to select patients who should respond to BRAF inhibitors. Different techniques are routinely used to determine BRAF status in clinical samples. However, low tumor cellularity and tumor heterogeneity can affect the sensitivity of somatic mutation detection. Digital PCR (dPCR) is a next-generation genotyping method that clonally amplifies nucleic acids and allows the detection and quantification of rare mutations. Our aim was to evaluate the clinical routine performance of a new dPCR-based test to detect and quantify BRAF mutation load in 47 paraffin-embedded cutaneous melanoma biopsies. We compared the results obtained by dPCR with high-resolution melting curve analysis and pyrosequencing or with one of the allele-specific PCR methods available on the market. dPCR showed the lowest limit of detection. dPCR and allele-specific amplification detected the highest number of mutated samples. For the BRAF mutation load quantification both dPCR and pyrosequencing gave similar results with strong disparities in allele frequencies in the 47 tumor samples under study (from 0.7% to 79% of BRAF V600E mutations/sample). In conclusion, the four methods showed a high degree of concordance. dPCR was the more-sensitive method to reliably and easily detect mutations. Both pyrosequencing and dPCR could quantify the mutation load in heterogeneous tumor samples.
Publication The Journal of molecular diagnostics: JMD
Volume 17
Issue 4
Pages 366-373
Date Jul 2015
Journal Abbr J Mol Diagn
Language eng
DOI 10.1016/j.jmoldx.2015.02.004
ISSN 1943-7811
Library Catalog PubMed
Extra PMID: 25952101
Tags Biopsy, DNA Mutational Analysis, DNA, Neoplasm, High-Throughput Nucleotide Sequencing, Humans, Melanoma, Mutation, original, Polymerase Chain Reaction, Proto-Oncogene Proteins B-raf, Skin Neoplasms
Date Added 2018/11/13 - 17:25:26
Date Modified 2019/05/21 - 14:55:48


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés